for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Abbvie Reaches Agreement With PCPA For Combination Venclexta With Rituximab As Treatment For Chronic Lymphocytic Leukemia

Dec 18 (Reuters) - Abbvie Inc:

* ABBVIE REACHES AN AGREEMENT WITH THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) FOR THE COMBINATION VENCLEXTA® WITH RITUXIMAB AS A TREATMENT FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

* ABBVIE INC - VENCLEXTA CONTINUES TO BE INVESTIGATED IN CLL AND OTHER HEMATOLOGICAL DISEASES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up